Immediate Impact

44 standout
Sub-graph 1 of 22

Citing Papers

Multiple sclerosis: emerging epidemiological trends and redefining the clinical course
2024 Standout
Iron imbalance in neurodegeneration
2024 Standout
2 intermediate papers

Works of Daniel Prefasi being referenced

Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)
2016
Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial
2013

Author Peers

Author Last Decade Papers Cites
Daniel Prefasi 148 86 87 26 416
Mayank Ajmera 59 61 33 40 382
Huah Shin Ng 155 79 44 34 504
Olga Carmona 268 27 103 31 428
Henriette Engberg 113 40 75 23 462
Fraser Moore 87 42 129 27 420
Vanessa Zimmerman 64 61 51 17 422
David Patry 169 39 111 15 503
Bong-Chul Chu 35 114 32 21 461
Daniel Kantor 162 24 124 33 391
Amy E. Sanders 46 39 46 18 419

All Works

Loading papers...

Rankless by CCL
2026